• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

New study suggests vegan diet could control blood sugar for people with, or at risk of, type 2 diabetes

Mar 30, 2021

A study supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC) – a partnership between Leicester’s Hospitals, the University of Leicester and Loughborough University – and NIHR Applied Research Collaboration East Midlands (ARC EM) into the effects of a vegan diet in people with or at risk of developing type 2 diabetes has concluded that a plant-based lifestyle may help control blood glucose levels.

Researchers on the ‘Plant Your Health’ study looked at whether a vegan diet could reduce the production of TMAO as well as improve blood sugar control in the body, and therefore reduce the risk of symptoms of type 2 diabetes. TMAO (or trimethylamine N-oxide) is a molecule produced when food, particularly from animal sources, is broken down in the gut. Its presence is associated with an increased risk of heart disease, which is often linked to type 2 diabetes.

The study followed 23 individuals who either had or were at risk of developing type 2 diabetes, or whose weight was defined as clinically obese. Participants were given a full health check, including TMAO, blood sugar and cholesterol levels. They were then asked to swap their regular meals with like-for-like vegan equivalents over a period of eight weeks and encouraged to keep their physical activity the same.
The researchers found that on average TMAO levels in participants almost halved after just one week, and remained relatively steady at eight weeks. However, when participants switched back to their regular diets at the end of the study, TMAO levels had rebounded to their original levels four weeks later.

Blood glucose levels were also found to decrease at weeks one and eight.

Professor Tom Yates, a professor of physical activity and sedentary behaviour at the University of Leicester, and co-author on the study, said: “Recent research into the causes of type 2 diabetes has found a strong association between a molecule in the blood called TMAO and increased risk of heart disease. TMAO is produced as a byproduct of how certain foods are broken down in the gut and has been associated with an increase in the buildup of plaque in the arteries, which can lead to heart problems.

“Research has found that TMAO is particularly linked to animal products in the diet such as red meat, eggs and dairy. Due to the increased risk of patients with type 2 diabetes also developing heart disease, research suggests that there is a connection between diet, type 2 diabetes and heart functioning.”

Dr Stavroula Argyridou, a registered dietitian who conducted the research, said: “Our findings suggest that a vegan diet could be an effective strategy for reducing TMAO and blood sugar levels in individuals with or at high risk of type 2 diabetes.

“This means it could provide a suitable alternative to a conventional diet that is usually recommended for people with type 2 diabetes. We would need to widen participation to see if these initially promising results are replicated in larger groups of patients, over a longer period of time, and with a control group.”

Diabetes rates are on the increase across all age groups, largely due to lifestyle choices such as low levels of physical activity, or being overweight or obese as a result of consuming more energy than we use. Type 2 diabetes represents a serious clinical and financial burden to the NHS. £8.8bn is spent for the treatment of this disease and its complications. Financial estimation studies project an indirect cost of £20 billion in 2035/2036 to the NHS budget. Therefore a range of suitable treatments is needed to prevent, manage and treat the condition in growing numbers of people.

The paper, ‘Evaluation of an 8-week vegan diet on plasma Trimethylamine-N-Oxide and post-challenge glucose in adults with dysglycemia or obesity’ is published in the Journal of Nutrition on 30 March 2021.

Ends

Category: Press ReleasesTag: Press Release

Sidebar

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}